Table 1 Demographic characteristics of MetS patients in the two treatment groups a
| Â | Control group (Fasting alone) | Carnitine group (Fasting + L-carnitine) | P-valueb |
|---|---|---|---|
Number | 15 | 15 | 1.00 |
Gender (Female/Male) | 10/5 | 11/4 | 0.702 |
Age (year) | 46.8 ± 10.9(27–65) | 46.9 ± 9.14(37–60) | 0.973 |
Body mass (kg) | 74.2 ± 6.9(59–86) | 75.1 ± 7.5(64.1-93) | 0.721 |
BMI (kg/m2) | 27.4 ± 2.0(25–32.6) | 28.2 ± 1.8(26.1-32.4) | 0.348 |
WC (cm) | 90.4 ± 4.99(83–98) | 94.1 ± 6.0(84–107) | 0.229 |
Metabolic disease | Â | Â | Â |
Hypertension | 4 | 5 | 0.702 |
Impaired glucose tolerance | 3 | 5 | 0.426 |
Dyslipidemia | 12 | 13 | 0.638 |